Clinicopathologic analysis of extracapsular extension in prostate cancer: Should the clinical target volume be expanded posterolaterally to account for microscopic extension?

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 4, 2006, Pages 999-1007

  Chao, K Kenneth ^a   Goldstein, Neal S ^a   Yan, Di ^a   Vargas, Carlos E ^b   Ghilezan, Michel I ^a   Korman, Howard J ^a   Kernen, Kenneth M ^a   Hollander, Jay B ^a   Gonzalez, Jose A ^a   Martinez, Alvaro A ^a   Vicini, Frank A ^a   Kestin, Larry L ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Extracapsular extension; Prostate; Prostatectomy; Prostatic neoplasms; Radiotherapy

Indexed keywords

ANTIGENS; BIOPSY; PATIENT MONITORING; TUMORS;

CLINICAL TARGET VOLUME (CTV); EXTRACAPSULAR EXTENSION (ECE); PROSTATE CANCER; PROSTATECTOMY; PROSTATIC NEOPLASMS;

RADIOTHERAPY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMAGING; MALE; METASTASIS; MICROCAPSULE; MICROSCOPY; PATHOLOGY; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CAPSULE; PROSTATECTOMY; RISK FACTOR; TUMOR BIOPSY;

AGED; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK;

EID: 33745220067     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.02.039     Document Type: Article

References (46)

1. Hanks G.E., Martz K.L., and Diamond J.J. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 15 (1988) 1299-1305
2. Hanks G.E., Hanlon A.L., Pinover W.H., et al. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am 5 (1999) 152-158
3. Hanks G.E., Hanlon A.L., Pinover W.H., et al. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys 46 (2000) 823-832
4. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 18 (2000) 3904-3911
5. Pollack A., Smith L.G., and von Eschenbach A.C. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys 48 (2000) 507-512
6. Vicini F.A., Abner A., Baglan K.L., et al. Defining a dose-response relationship with radiotherapy for prostate cancer. Is more really better?. Int J Radiat Oncol Biol Phys 51 (2001) 1200-1208
7. Martinez A.A., Yan D., Lockman D., et al. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1226-1234
8. Kupelian P.A., Mohan D.S., Lyons J., et al. Higher than standard radiation doses (≥72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 46 (2000) 567-574
9. Kupelian P.A., Buchsbaum J.C., Reddy C.A., et al. Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason ≤6, and pretreatment prostate-specific antigen ≤10). Int J Radiat Oncol Biol Phys 50 (2001) 621-625
10. Lyons J.A., Kupelian P.A., Mohan D.S., et al. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. Urology 55 (2000) 85-90
11. Valicenti R., Lu J., Pilepich M., et al. Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials. J Clin Oncol 18 (2000) 2740-2746
12. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41 (1998) 491-500
13. Horwitz E.M., Hanlon A.L., Pinover W.H., et al. Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques. Cancer 92 (2001) 1281-1287
14. McNeal J.E., Redwine E.A., Freiha F.S., et al. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12 (1988) 897-906
15. McNeal J.E., Villers A.A., Redwine E.A., et al. Capsular penetration in prostate cancer. Significance for natural history and treatment. Am J Surg Pathol 14 (1990) 240-247
16. Villers A., McNeal J.E., Redwine E.A., et al. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 142 (1989) 763-7658
17. Rosen M.A., Goldstone L., Lapin S., et al. Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. J Urol 148 (1992) 331-337
18. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. J Am Med Assoc 277 (1997) 1445-1451
19. Pisansky T.M., and Davis B.J. Predictive factors in localized prostate cancer. Implications for radiotherapy and clinical trial design. Semin Urol Oncol 18 (2000) 93-107
20. Egawa S., Suyama K., Matsumoto K., et al. Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men. Urology 52 (1998) 433-440
21. Davis B.J., Pisansky T.M., Wilson T.M., et al. The radial distance of extraprostatic extension of prostate carcinoma. Implications for prostate brachytherapy. Cancer 85 (1999) 2630-2637
22. Teh B.S., Bastasch M.D., Mai W.Y., et al. Predictors of extracapsular extension and its radial distance in prostate cancer. Implications for prostate IMRT, brachytherapy, and surgery. Cancer J 9 (2003) 454-460
23. Teh B.S., Bastasch M.D., Wheeler T.M., et al. IMRT for prostate cancer. Defining target volume based on correlated pathologic volume of disease. Int J Radiat Oncol Biol Phys 56 (2003) 184-191
24. Sohayda C., Kupelian P.A., Levin H.S., et al. Extent of extracapsular extension in localized prostate cancer. Urology 55 (2000) 382-386
25. American Joint Committee on Cancer. Prostate. In: Beahrs O.H., Henson D.E., Hutter R.V.P., and Kennedy B.J. (Eds). AJCC Cancer Staging Manual. 4the ed. (1992), Lippincott-Raven, Philadelphia 181-186
26. Obek C., Louis P., Civantos F., et al. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. J Urol 161 (1999) 494-498
27. Helander K.G. Studies on the rate of dehydration of histological specimens. J Microsc 145 (1987) 351-355
28. Schned A., Wheeler K., Hodorowski C., et al. Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol 20 (1996) 1501-1506
29. Partin A., Epstein J., Cho K., et al. Morphometric measurement of tumor volume and percent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 141 (1989) 341-345
30. Greene D., Egawa S., Neerhut G., et al. The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer. J Urol 145 (1991) 324-329
31. Schmid H., and McNeal J. An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Prostate 4 Suppl (1992) 129-138
32. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose resonse. Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Riol Phys 53 (2002) 1097-1105
33. Zelefsky M., Fuks Z., and Leibel S. Intensity-modulated radiation therapy for prostate cancer. Semin Rad Oncol 12 (2002) 229-237
34. Kupelian P.A., Reddy C.A., Klein E.A., et al. Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer. Preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 51 (2001) 988-993
35. Price R.A., Murphy S., McNeeley S.W., et al. A method for increased dose conformity and segment reduction for sMLC delivered IMRT treatment of the prostate. Int J Radiat Oncol Biol Phys 57 (2003) 843-852
36. Beard C.J., Kijewski P., Bussiere M., et al. Analysis of prostate and seminal vesicle motion. Implications for treatment planning. Int J Radiat Oncol Biol Phys 34 (1996) 451-458
37. Yan D., Wong J., Vicini F., et al. Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors. Int J Radiat Oncol Biol Phys 38 (1997) 197-206
38. Yan D., Ziaja E., Jaffray D., et al. The use of adaptive radiation therapy to reduce setup error. A prospective clinical study. Int J Radiat Oncol Biol Phys 41 (1998) 715-720
39. Yan D., Lockman D., Brabbins D., et al. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 289-302
40. Madsen B.L., Hsi R.A., Pham H.T., et al. Intrafractional stability of the prostate using a stereotactic radiotherapy technique. Int J Radiat Oncol Biol Phys 57 (2003) 1285-1291
41. Livley J.E., Cowan R.A., Wiley J.P., et al. Hypofractionated conformal radiotherapy in carcinoma of the prostate. Five-year outcome analysis. Int J Radiat Oncol Biol Phys 57 (2003) 1254-1259
42. Chao K., Yan D., Lockman D., et al. Rethinking the CTV definition. Optimal implementation of prostate IGRT requires attention to extracapsular extension. Presented at the 47th ASTRO Annual Meeting (2005) October 16-20
43. Roach III M., Faillace-Akazawa P., Malfatti C., et al. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 35 (1996) 1011-1018
44. Rasch C., Barillot I., Remeijer P., et al. Definition of the prostate in CT and MRI. A multi-observer study. Int J Radiat Oncol Biol Phys 43 (1999) 57-66
45. Villeirs G., Verstraete K., De Neve W., et al. Magnetic resonance imaging anatomy of the prostate and periprostatic area. A guide for radiotherapists. Radiother Oncol 76 (2005) 99-106
46. Hricak H., Wang L., Wei D., et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundle during radical retropubic prostatectomy. Cancer 100 (2004) 2655-2663